Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Digene Corp. — Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

183 daysmedian FDA review time
669 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K010891MODIFICATION TO HYBRID CAPTURE II CT/GC TEST, MODEL 03M90-01Digene Corp.2001-09-251830
K010892MODIFICATION HYBRID CAPTURE II CT-ID DNA TEST, MODEL 03M91-0Digene Corp.2001-09-241820
K010893MODIFICATION TO HYBRID CAPTURE 2 GC-ID DNA TEST, MODEL 03M92Digene Corp.2001-09-241820
K981567HYBRID CAPTURE II CT/GC TESTDigene Corp.2000-02-296690
K981485HYBRID CAPTURE II GC-IDDigene Corp.1999-11-295840
K990023HYBRID CAPTURE II CT-ID TESTDigene Corp.1999-10-252931
K974901HYBRID CAPTURE SYSTEM CMV DNA ASSAYDigene Corp.1998-09-292720
K980120DIGENE DML 2000 MICROPLATE LUMINOMETERDigene Corp.1998-02-06240
K971586DIGENE CERVICAL BRUSHDigene Corp.1997-09-191410

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda